IGC Pharma, Inc.
IGC$27M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaPOTOMAC70 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Mar 30, 2026
23dMarket Overview
Stock performance and key metrics
IGC News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IGC-AD1-Active | Phase 2 | Alzheimer Disease | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply